Back
Apyx Medical 10K Form
Sell
33
APYX
Apyx Medical
Last Price:
$1.58
Seasonality Move:
5.24%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2020-08-10 | 10Q | APYX/Apyx Medical Quarterly |
2020-05-11 | 10Q | APYX/Apyx Medical Quarterly |
2020-05-08 | 10Q | APYX/Apyx Medical Quarterly |
2020-03-31 | 10K | APYX/Apyx Medical Annual |
2019-11-15 | 10Q | APYX/Apyx Medical Quarterly |
2019-08-07 | 10Q | APYX/Apyx Medical Quarterly |
Receive APYX News And Ratings
See the #1 stock for the next 7 days that we like better than APYX
APYX Financial Statistics
Sales & Book Value
Annual Sales: | $52.3M |
---|---|
Cash Flow: | $-4.6M |
Price / Cash Flow: | 0 |
Annual Sales: | $0.32 |
Price / Book: | 5.35 |
Profitability
EPS (TTM): | -0.83000 |
---|---|
Net Income (TTM): | $-28.4M |
Gross Margin: | $33.8M |
Return on Equity: | -132.8% |
Return on Assets: | -42.39% |
Apyx Medical Earnings Forecast
Key Apyx Medical Financial Ratios
-
The Gross Profit Margin over the past 29 years for APYX is 64.49%.
-
The Selling, General & Administrative Expenses for APYX have been equal to 93.35% of Gross Profit Margin.
-
The Research & Development expenses have been 9.25% of Revenue.
-
The Interest Expense is -13.24% of Operating Income.
-
The Net Earning history of APYX is -35.75% of Total Revenues.
-
Per Share Earnings over the last 29 years have been positive in 12 years.
Apyx Medical Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Health Care Equipment & Supplies |
Sector: | Health Care |
Current Symbol: | APYX |
CUSIP: | 03837C |
Website: | apyxmedical.com |
Debt
Debt-to-Equity Ratio: | 3.07 |
---|---|
Current Ratio: | 5.46 |
Quick Ratio: | 4.3 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 0 |
APYX Technical Analysis vs Fundamental Analysis
Sell
33
Apyx Medical (APYX)
is a Sell
Is Apyx Medical a Buy or a Sell?
-
Apyx Medical stock is rated a SellThe current Apyx Medical [APYX] share price is $1.57. The Score for APYX is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.